Research programme: indirubin analogues - Oncotest GmbH
Alternative Names: 5-methyl indirubin; 5MILatest Information Update: 02 Oct 2021
At a glance
- Originator Oncotest
- Class Antineoplastics; Indoles; Small molecules
- Mechanism of Action Cyclin-dependent kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Solid-tumours in Germany (PO)
- 05 Dec 2006 Preclinical trials in Solid tumours in Germany (PO)